|
Volumn 19, Issue 1, 2001, Pages 101-104
|
Achievement of complete remission in refractory Hodgkin's disease with prolonged infussion of gemcitabine
a a a a a a |
Author keywords
Gemcitabine; Hodgkin's disease; Nucleoside analogues; Progression; Toxicity
|
Indexed keywords
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
GEMCITABINE;
PREDNISONE;
PROCARBAZINE;
VINCRISTINE;
ADULT;
ANEMIA;
ARTICLE;
BONE MARROW METASTASIS;
CANCER GROWTH;
CANCER REGRESSION;
CASE REPORT;
CLINICAL FEATURE;
DISEASE COURSE;
DOSE RESPONSE;
HODGKIN DISEASE;
HUMAN;
LEUKOPENIA;
NEUTROPENIA;
PRIORITY JOURNAL;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADULT;
ANTIMETABOLITES, ANTINEOPLASTIC;
BONE MARROW;
DEOXYCYTIDINE;
DISEASE-FREE SURVIVAL;
DRUG EVALUATION;
HODGKIN DISEASE;
HUMANS;
INFUSIONS, INTRAVENOUS;
RECURRENCE;
REMISSION INDUCTION;
SALVAGE THERAPY;
TREATMENT OUTCOME;
|
EID: 0035090424
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006478702342 Document Type: Article |
Times cited : (18)
|
References (19)
|